(MedPage Today) — Could be first new treatment for diabetic retinopathy in many years
Uncategorized
VIDEO: Surgeon discusses intense pulsed light system to treat meibomian gland disease
LAS VEGAS — At the American Academy of Ophthalmology annual meeting, Sheila Barbarino, MD, FACS, discusses treating meibomian gland disease with the intense pulsed light system , which she is currently working to gain approval from the Institutional Review Board.
Aerpio Therapeutics Reports Positive Clinical Results from the Phase 2a Study of Lead Candidate, AKB-9778, in Diabetic Macular Edema (DME): The TIME-2 Trial
CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced that clinical data from the company’s phase 2a study of its lead candidate, AKB-9778, for the treatment of patients with DME, were reported in an oral presentation delivered by Peter Campochiaro, MD, from Johns Hopkins Wilmer Eye Institute, during the Retina Subspecialty Day at the ongoing American Academy of Ophthalmology (AAO) Annual M
Do No Harm: Protecting Patient Data
(MedPage Today) — Experts explore the dangers of cyberattacks and possible strategies for identity management
AMA Adopts Policy on Med Student Mental Health Access
(MedPage Today) — Giving patients greater access to naloxone was also a focus
Uncategorized
Complications persist after phaco in eyes with pseudoexfoliation and nonsutured CTR implantation
LAS VEGAS — Nonsutured capsular tension ring implantation after phacoemulsification did not prevent capsular or IOL complications in eyes with pseudoexfoliation, according to a study presented here.“Sadly, there is very scarce literature on the postoperative outcomes [of capsular tension rings (CTRs)],” Yan-Ning Neo, MBCHB, said at the American Academy of Ophthalmology annual meeting. “Therefore, we question whether nonsutured CTR implantations prevent postoperative complications in pseudoexfoliation eyes with zonular weakness that underwent phacoemulsification with IOL implantation.”